GAM
ADMA icon

Gotham Asset Management’s ADMA Biologics ADMA Stock Holding History

Gotham Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,627
Closed -$249K – 1753
2025
Q4 		$249K Buy
13,627
+2,616
+24% +$44.1K ﹤0.01% 1616
2025
Q3 		$161K Sell
11,011
-97,982
-90% -$1.68M ﹤0.01% 1632
2025
Q2 		$1.98M Sell
108,993
-55,254
-34% -$1.13M 0.01% 932
2025
Q1 		$3.26M Sell
164,247
-2,447
-1% -$42.3K 0.03% 647
2024
Q4 		$2.86M Buy
166,694
+2,129
+1% +$40.1K 0.03% 639
2024
Q3 		$3.29M Buy
164,565
+86,417
+111% +$1.34M 0.03% 597
2024
Q2 		$874K Sell
78,148
-17,332
-18% -$145K 0.01% 927
2024
Q1 		$630K Buy
95,480
+25,891
+37% +$142K 0.01% 973
2023
Q4 		$315K Sell
69,589
-6,030
-8% -$22.3K 0.01% 1126
2023
Q3 		$271K Buy
75,619
+14,564
+24% +$56.1K 0.01% 1141
2023
Q2 		$225K Buy
61,055
+29,532
+94% +$109K ﹤0.01% 1201
2023
Q1 		$104K Sell
31,523
-10,987
-26% -$38K ﹤0.01% 1287
2022
Q4 		$165K Buy
+42,510
New +$131K ﹤0.01% 1146

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Gotham Asset Management's ADMA Position: Q1 2026 in Review

Gotham Asset Management sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 13,627 shares — an estimated $249K sold.

Gotham Asset Management first reported a position in ADMA in Q4 2022 and held it in 13 quarters. The position peaked at $3.29M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Gotham Asset Management reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Gotham Asset Management sold 13,627 ADMA Biologics shares in Q1 2026, an estimated $249K.
  • Gotham Asset Management first reported a position in ADMA Biologics in Q4 2022 and held it in 13 quarters.
  • Gotham Asset Management's ADMA Biologics position peaked at $3.29M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.